Murat Kara1, Servet Yolbaş2, Cem Şahin3, Süleyman Serdar Koca2. 1. Department of Medical Genetics, Muğla Sıtkı Koçman University School of Medicine, Muğla, Turkey. 2. Department of Rheumatology, Fırat University School of Medicine, Elazığ, Turkey. 3. Department of Internal Medicine, Muğla Sıtkı Koçman University School of Medicine, Muğla, Turkey.
Abstract
OBJECTIVE: Sirtuins (SIRTs) play a prominent role in metabolism, apoptosis, aging, inflammation, and epigenetics. Inflammation, apoptosis, and epigenetics are pathogenic issues in rheumatoid arthritis (RA). This study aimed to evaluate SIRT2 and SIRT3 mRNA expressions in patients with RA. MATERIAL AND METHODS: Fifty-four patients with RA and 26 healthy controls were enrolled. Disease activity was determined using the disease activity score (DAS) 28-erythrocyte sedimentation rate (ESR) (score of >2.6 was considered to be active). SIRT2 and SIRT3 mRNA expressions in the extracellular plasma were investigated by real-time PCR. RESULTS: SIRT3 mRNA expression was higher in the RA group than in the healthy control group (4.64 fold, p<0.001), whereas SIRT2 mRNA expression was relatively lower in the RA group than in the healthy control group (0.55 fold, p=0.109). However, SIRT2 (1.73 fold, p=0.065) and SIRT3 (3.58 fold, p=0.051) mRNA expressions were relatively higher in patients with active RA than in those with inactive RA. CONCLUSION: In RA, SIRT3 mRNA expression is increased, whereas SIRT2 mRNA expression is decreased. Conversely, SIRT2 and SIRT3 mRNA expressions increase in active RA. Therefore, the fate of each SIRT may differ in RA.
OBJECTIVE: Sirtuins (SIRTs) play a prominent role in metabolism, apoptosis, aging, inflammation, and epigenetics. Inflammation, apoptosis, and epigenetics are pathogenic issues in rheumatoid arthritis (RA). This study aimed to evaluate SIRT2 and SIRT3 mRNA expressions in patients with RA. MATERIAL AND METHODS: Fifty-four patients with RA and 26 healthy controls were enrolled. Disease activity was determined using the disease activity score (DAS) 28-erythrocyte sedimentation rate (ESR) (score of >2.6 was considered to be active). SIRT2 and SIRT3 mRNA expressions in the extracellular plasma were investigated by real-time PCR. RESULTS:SIRT3 mRNA expression was higher in the RA group than in the healthy control group (4.64 fold, p<0.001), whereas SIRT2 mRNA expression was relatively lower in the RA group than in the healthy control group (0.55 fold, p=0.109). However, SIRT2 (1.73 fold, p=0.065) and SIRT3 (3.58 fold, p=0.051) mRNA expressions were relatively higher in patients with active RA than in those with inactive RA. CONCLUSION: In RA, SIRT3 mRNA expression is increased, whereas SIRT2 mRNA expression is decreased. Conversely, SIRT2 and SIRT3 mRNA expressions increase in active RA. Therefore, the fate of each SIRT may differ in RA.
Authors: Connie M Krawczyk; Thomas Holowka; Jie Sun; Julianna Blagih; Eyal Amiel; Ralph J DeBerardinis; Justin R Cross; Euihye Jung; Craig B Thompson; Russell G Jones; Edward J Pearce Journal: Blood Date: 2010-03-29 Impact factor: 22.113
Authors: Karin M Rothgiesser; Süheda Erener; Susanne Waibel; Bernhard Lüscher; Michael O Hottiger Journal: J Cell Sci Date: 2010-11-16 Impact factor: 5.285
Authors: Hyun-Seok Kim; Krish Patel; Kristi Muldoon-Jacobs; Kheem S Bisht; Nukhet Aykin-Burns; J Daniel Pennington; Riet van der Meer; Phuongmai Nguyen; Jason Savage; Kjerstin M Owens; Athanassios Vassilopoulos; Ozkan Ozden; Seong-Hoon Park; Keshav K Singh; Sarki A Abdulkadir; Douglas R Spitz; Chu-Xia Deng; David Gius Journal: Cancer Cell Date: 2010-01-19 Impact factor: 31.743
Authors: Daniel Wendling; Wasim Abbas; Marie Godfrin-Valnet; Amit Kumar; Xavier Guillot; Kashif Aziz Khan; Claire Vidon; Laurie Coquard; Eric Toussirot; Clément Prati; Georges Herbein Journal: PLoS One Date: 2015-03-23 Impact factor: 3.240
Authors: Kai Sun; Xuan Wang; Na Fang; Ao Xu; Yao Lin; Xiaofang Zhao; Adil J Nazarali; Shaoping Ji Journal: J Cell Mol Med Date: 2020-06-09 Impact factor: 5.310
Authors: Noemi Sola-Sevilla; Ana Ricobaraza; Ruben Hernandez-Alcoceba; Maria S Aymerich; Rosa M Tordera; Elena Puerta Journal: Int J Mol Sci Date: 2021-03-18 Impact factor: 5.923